Anatomic Pathology Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Anatomic Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Histopathology, Cytopathology, Surgical Pathology, Others), By Technique (Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing, Others), By Application (Disease Diagnosis, Drug Discovery and Development), By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Others) By Region & Competition, 2021-2031F
報告摘要
Market Overview
The global anatomic pathology market is projected for significant growth, expanding from USD 36.09 billion in 2025 to USD 57.21 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.98%. This sector involves the microscopic study of tissues and cells to understand disease progression and inform treatment choices. Growth is largely fueled by an increasing worldwide prevalence of chronic diseases and an aging population, both of which drive a higher demand for biopsy procedures. This upward trend is further bolstered by a stronger emphasis on early detection and proactive healthcare strategies. For instance, the American Cancer Society anticipates around 2 million new cancer diagnoses in the United States in 2025, underscoring the vital role of precise pathological assessment.
A substantial obstacle to the market's expansion, however, is the scarcity of skilled pathologists available to manage the escalating diagnostic requirements. This shortage of specialized personnel limits the operational capabilities of laboratories, resulting in delayed result reporting, which can negatively affect patient outcomes. Therefore, the restricted availability of these expert professionals acts as a key impediment that could hinder the global scalability of anatomic pathology services.
Market Driver
The primary driver behind the anatomic pathology market's expansion is the escalating worldwide occurrence of cancer and other chronic diseases, which inherently increases the need for diagnostic procedures. As more complex cancer cases emerge, laboratories are under pressure to efficiently process tissue samples while ensuring high diagnostic accuracy crucial for effective treatment planning. This demand is intensified by the imperative for precise tumor staging and grading, which are essential for guiding advanced therapeutic interventions. The World Health Organization's International Agency for Research on Cancer reported in February 2024 that the global cancer burden reached approximately 20 million new cases in 2022, with a projected 77% increase by 2050, highlighting this pressing need.
Concurrently, the adoption of artificial intelligence (AI) and digital pathology solutions is revolutionizing laboratory operations, improving both workflow efficiency and diagnostic accuracy. Through the digitization of glass slides and the application of machine learning algorithms, pathologists can automate routine tasks, achieve more precise quantification of biomarkers, and alleviate the operational strain caused by workforce shortages. This technological evolution is fostering substantial industry consolidation and investment, focused on scaling digital capabilities throughout healthcare systems. For example, Roche expanded its digital pathology ecosystem in September 2024 by incorporating over 20 advanced AI algorithms from eight partners to aid cancer diagnosis. Similarly, in May 2024, Quest Diagnostics acquired specific assets from PathAI Diagnostics, signaling a broader trend toward tech-enabled services aimed at accelerating AI adoption across its pathology network.
Market Challenge
The foremost challenge impeding the expansion of the Global Anatomic Pathology Market is the severe dearth of qualified pathologists. This insufficient workforce creates a critical bottleneck within the diagnostic process, directly limiting the number of specimens laboratories can efficiently handle. With the increasing demand for biopsy procedures and intricate disease analyses, the lack of adequate specialized personnel compels current staff to work beyond their sustainable capacity. This limitation invariably causes delays in test results and curtails the capacity of pathology services to scale operations to satisfy worldwide requirements, consequently hindering revenue growth and market development initiatives.
Recent industry figures underscore the extent of this operational pressure. The Royal College of Pathologists reported in 2025 that 60% of consultants were working past their contracted hours to manage the growing clinical workload and fill staff vacancies. This dependence on an overstretched workforce emphasizes the gravity of the imbalance between supply and demand. As a result, laboratories cannot fully leverage the increasing diagnostic needs, given that the scarcity of experts impedes the seamless integration of larger caseloads and restricts overall market advancement.
Market Trends
The growing adoption of companion diagnostics for precision medicine is fundamentally reshaping the anatomic pathology market, steering it from traditional morphological diagnosis toward molecular-guided therapeutic choices. As pharmaceutical firms increasingly develop targeted therapies alongside specific diagnostic assays, pathology laboratories are required to implement sophisticated testing protocols capable of precisely identifying patients who qualify for these treatments. This trend is directly supported by the strong pipeline of precision medicines, all of which necessitate validated biomarkers for their prescription. The Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized treatments for rare diseases in 2023, signifying a notable rise and underscoring the increasing dependence on integrated diagnostic-therapeutic pairings in clinical practice.
Concurrently, the amalgamation of molecular and anatomic pathology diagnostics is prompting the incorporation of comprehensive genomic profiling into standard tissue-based workflows. Pathology laboratories are advancing beyond testing for single analytes, embracing next-generation sequencing platforms that can analyze hundreds of genes from a single biopsy. This approach streamlines the diagnostic process and preserves valuable tissue samples. Such integration allows pathologists to offer a more complete understanding of tumor biology and expedites the provision of actionable insights for intricate oncology cases. Illustrating this transition, Illumina announced in August 2024 that the FDA approved its TruSight Oncology Comprehensive test, which profiles over 500 genes to link patients with solid tumors to suitable targeted therapies.
Key Market Players
* Quest Diagnostics Inc
* Danaher Corporation
* PHC Holdings Corporation
* Laboratory Corporation of America Holdings
* F. Hoffmann-La Roche AG
* Agilent Technologies Inc.
* Cardinal Health Inc.
* Sakura Finetek USA Inc.
* NeoGenomics Laboratories Inc.
Report Scope
In this report, the Global Anatomic Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Anatomic Pathology Market, By Type
* Histopathology
* Cytopathology
* Surgical Pathology
* Others
# Anatomic Pathology Market, By Technique
* Special Staining
* Immunohistochemistry
* Electron Microscopy
* Genetic Testing
* Others
# Anatomic Pathology Market, By Application
* Disease Diagnosis
* Drug Discovery
* Development
# Anatomic Pathology Market, By End-User
* Hospitals
* Research Laboratories
* Diagnostic Laboratories
* Others
# Anatomic Pathology Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Anatomic Pathology Market.
Available Customizations:
Global Anatomic Pathology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Anatomic Pathology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Histopathology, Cytopathology, Surgical Pathology, Others)
5.2.2. By Technique (Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing, Others)
5.2.3. By Application (Disease Diagnosis, Drug Discovery, Development)
5.2.4. By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Others)
5.2.5. By Region
5.2.6. By Company (2025)
5.3. Market Map
6. North America Anatomic Pathology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Technique
6.2.3. By Application
6.2.4. By End-User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Anatomic Pathology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Technique
6.3.1.2.3. By Application
6.3.1.2.4. By End-User
6.3.2. Canada Anatomic Pathology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Technique
6.3.2.2.3. By Application
6.3.2.2.4. By End-User
6.3.3. Mexico Anatomic Pathology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Technique
6.3.3.2.3. By Application
6.3.3.2.4. By End-User
7. Europe Anatomic Pathology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Technique
7.2.3. By Application
7.2.4. By End-User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Anatomic Pathology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Technique
7.3.1.2.3. By Application
7.3.1.2.4. By End-User
7.3.2. France Anatomic Pathology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Technique
7.3.2.2.3. By Application
7.3.2.2.4. By End-User
7.3.3. United Kingdom Anatomic Pathology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Technique
7.3.3.2.3. By Application
7.3.3.2.4. By End-User
7.3.4. Italy Anatomic Pathology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Technique
7.3.4.2.3. By Application
7.3.4.2.4. By End-User
7.3.5. Spain Anatomic Pathology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Technique
7.3.5.2.3. By Application
7.3.5.2.4. By End-User
8. Asia Pacific Anatomic Pathology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Technique
8.2.3. By Application
8.2.4. By End-User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Anatomic Pathology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Technique
8.3.1.2.3. By Application
8.3.1.2.4. By End-User
8.3.2. India Anatomic Pathology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Technique
8.3.2.2.3. By Application
8.3.2.2.4. By End-User
8.3.3. Japan Anatomic Pathology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Technique
8.3.3.2.3. By Application
8.3.3.2.4. By End-User
8.3.4. South Korea Anatomic Pathology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Technique
8.3.4.2.3. By Application
8.3.4.2.4. By End-User
8.3.5. Australia Anatomic Pathology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Technique
8.3.5.2.3. By Application
8.3.5.2.4. By End-User
9. Middle East & Africa Anatomic Pathology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Technique
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Anatomic Pathology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Technique
9.3.1.2.3. By Application
9.3.1.2.4. By End-User
9.3.2. UAE Anatomic Pathology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Technique
9.3.2.2.3. By Application
9.3.2.2.4. By End-User
9.3.3. South Africa Anatomic Pathology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Technique
9.3.3.2.3. By Application
9.3.3.2.4. By End-User
10. South America Anatomic Pathology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Technique
10.2.3. By Application
10.2.4. By End-User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Anatomic Pathology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Technique
10.3.1.2.3. By Application
10.3.1.2.4. By End-User
10.3.2. Colombia Anatomic Pathology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Technique
10.3.2.2.3. By Application
10.3.2.2.4. By End-User
10.3.3. Argentina Anatomic Pathology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Technique
10.3.3.2.3. By Application
10.3.3.2.4. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Anatomic Pathology Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Quest Diagnostics Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Danaher Corporation
15.3. PHC Holdings Corporation
15.4. Laboratory Corporation of America Holdings
15.5. F. Hoffmann-La Roche AG
15.6. Agilent Technologies Inc.
15.7. Cardinal Health Inc.
15.8. Sakura Finetek USA Inc.
15.9. NeoGenomics Laboratories Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們